Literature DB >> 22113295

Methods for analyzing histone citrullination in chromatin structure and gene regulation.

Pingxin Li1, Jing Hu, Yanming Wang.   

Abstract

Histone posttranslational modifications play significant roles in regulating chromatin structure and gene expression. One of the histone modifications, histone citrullination, is catalyzed by an enzyme called peptidylarginine deiminase 4 (PAD4, also called PADI4), which converts both histone arginine (Arg) and mono-methyl arginine residues to citrulline. Recent studies have found that histone citrullination counteracts the effect of histone arginine methylation and functions as a repressive marker to turn off gene expression. Here, we describe assays to study histone citrullination by PAD4 in vitro and in vivo. We also describe approaches to measure histone citrullination levels at gene promoters using chromatin immunoprecipitation assay and analyze the effects of PAD4 inhibitor on cell cycle and apoptosis by flow cytometry. These methods would be useful techniques to study this unique histone modification.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22113295     DOI: 10.1007/978-1-61779-376-9_31

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Factors Associated with Promoted Proliferation of Osteosarcoma by Peptidylarginine Deiminase 4.

Authors:  Jianping Guo; Lei Yin; Xuezhong Zhang; Peng Su; Qiaoli Zhai
Journal:  Biomed Res Int       Date:  2021-05-15       Impact factor: 3.411

2.  Potential role for PADI-mediated histone citrullination in preimplantation development.

Authors:  Rui Kan; Mei Jin; Venkataraman Subramanian; Corey P Causey; Paul R Thompson; Scott A Coonrod
Journal:  BMC Dev Biol       Date:  2012-06-19       Impact factor: 1.978

Review 3.  Histone citrullination: a new target for tumors.

Authors:  Dongwei Zhu; Yue Zhang; Shengjun Wang
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

Review 4.  Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.

Authors:  Eleftheria Hatzimichael; Konstantinos Lagos; Van Ren Sim; Evangelos Briasoulis; Tim Crook
Journal:  EXCLI J       Date:  2014-08-26       Impact factor: 4.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.